Herbert Loong, Advisor at Greater Bay Area International Clinical Trial Institute, and Steering Committee Member at Lung Cancer Policy Network, shared a post on X:
“Starting my 20+ hour journey on the Airport Express heading to Copenhagen for ESMO – Eur. Oncology, IASLC, ELCC 2026!
Looking forward to meeting multidisciplinary thoracic oncology friends from around the World! Check out our poster 60P illustrating Late Presenting Adverse Events (LPAEs) of RET inhibitors.”
Other articles about ELCC on OncoDaily.